verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler mylan pharmaceuticals inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 120 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-6320
Product ID 0378-6320_c63ca9bc-5c77-4e53-8adf-9cfd16bfe012
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075138
Listing Expiration 2026-12-31
Marketing Start 1999-05-20

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03786320
Hyphenated Format 0378-6320

Supplemental Identifiers

RxCUI
897612 897618 897624
UPC
0303786380015 0303786320011 0303786440016
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA075138 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6320-01)
source: ndc

Packages (1)

Ingredients (1)

verapamil hydrochloride (120 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c63ca9bc-5c77-4e53-8adf-9cfd16bfe012", "openfda": {"upc": ["0303786380015", "0303786320011", "0303786440016"], "unii": ["V3888OEY5R"], "rxcui": ["897612", "897618", "897624"], "spl_set_id": ["c86084bc-33aa-eece-5a96-6c0dad2d1a32"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6320-01)", "package_ndc": "0378-6320-01", "marketing_start_date": "19990520"}], "brand_name": "Verapamil Hydrochloride", "product_id": "0378-6320_c63ca9bc-5c77-4e53-8adf-9cfd16bfe012", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0378-6320", "generic_name": "verapamil hydrochloride", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA075138", "marketing_category": "ANDA", "marketing_start_date": "19990520", "listing_expiration_date": "20261231"}